Many polycyclic aromatic hydrocarbons (PAHs) are known carcinogens. A considerable amount of research has been devoted to predicting the genotoxic, tumor-initiating potential of PAHs based on chemical structure. However, information on the correlation of structure with the non-genetoxic, epigenetic events of tumor promotion is sparse. PAHs containing a bay or bay-like region were shown to be potent inhibitors of gap-junctional intercellular communication (GJIC), an epigenetic event involved in the removal of an initiated cell from growth suppression. We tested the epigenetic toxicity of PAHs containing bay-like regions by comparing the effects of methylated vs. chlorinated isomers of anthracene on the temporal activation of mitogen-activated protein kinase (MAPK) and the regulation of GJIC. Specifically, we used anthracene, 1-methylanthracene, 2-methylanthracene, 9-methylanthracene, 9,10-dimethylanthracene, 1-chloroanthracene, 2-chloroanthracene, and 9-chloroanthracene. We determined the effect of these compounds on GJIC and on the activation of extracellular receptor kinase (ERK 1 and 2), a MAPK, in F344 rat liver epithelial cells. Results showed that bay or bay-like regions, formed by either chlorine or a methyl group, reversibly inhibited GJIC at the same doses, time, and time of recovery, whereas the linear-planar isomers had no effect on GJIC. Similarly, the GJIC-inhibitory isomers also induced the phosphorylation of ERK 1 and ERK 2, while the non-inhibitory isomers had no effect on the activation of these MAPKs. MAPK activation occurred 10 -20 min after the inhibition of GJIC, which indicates that MAPK is not involved in the initial regulation of GJIC; instead altered GJIC may be affecting MAPK activation. The present study revealed that there are structural determinants of PAHs, which clearly affect epigenetic events known to be involved in the non-genetoxic steps of tumor promotion. These events are the release of a cell from growth suppression involving the reduction of GJIC, followed by the activation of intracellular mitogenic events.
Polycyclic aromatic hydrocarbons (PAHs) are common environmental pollutants that are strongly suspected of being carcinogenic to humans (IARC, 1983 (IARC, , 1984 . Considerable research has been devoted to predicting the carcinogenicity of PAHs based on their chemical structures (Dipple et al., 1984; Upham et al., 1998) . However, structure-activity relationships of PAHs reported in the literature focus exclusively on either the genotoxic tumor initiation or the complete carcinogenic properties of these compounds (Dipple, 1976; Dipple et al., 1984) . The carcinogenic risk of PAHs to humans does not rest solely on the genotoxic-initiating properties of a chemical. Many suspected carcinogens are not genotoxic (Ashby and Tennant, 1991) , and many genotoxic agents are noncarcinogenic and lack initiating activity (Ashby and Tennant, 1991) . PAHs have been shown to induce the following: the early genes, c-jun and c-fos (Parrish et al., 1998) ; the release of intracelluar stores of Ca 2ϩ (Tannheimer et al., 1997) ; changes in intracellular pH (Beech, 1991) ; activation of protein tyrosine kinases (Archuleta et al., 1993) ; and the non-genotoxic induction of cell proliferation (Zhang and Ramos, 1997) . Therefore, it is important to consider the epigenetic and non-genotoxic, tumor-promoting properties of PAHs.
Carcinogenesis consists of distinct operational phases of initiation, promotion, and progression . These conceptual phases were derived from in vivo observations, and their underlying cellular mechanisms are not clearly understood, but epigenetic as well as genotoxic events are involved (Trosko, 1997; Trosko et al., 1996) . Initiation, an irreversible event, has been hypothesized to be a consequence of mutations by which a normal stem cell could be irreversibly altered to prevent terminal differentiation . The operational phase of promotion is a reversible and interruptible event, which involves an environmental stimulus that prompts an initiated stem cell to clonally expand (proliferate) into a tumor (Barrett, 1990; Boutwell, 1964; Boyd and Harris, 1991; Holliday, 1987) . Clearly, the assessment of a carcinogenic risk of a chemical to humans must also include data on the non-genotoxic phases of cancer.
The non-genotoxic mechanism that triggers clonal expansion of an initiated cell involves "epigenetic events,Љ defined as the alteration of gene expression at the transcriptional, translational, and post-translational levels (Trosko and Ruch, 1998) . Epigenetic chemicals reversibly alter the genetic phenotype of a cell by interacting with a finite number of intracellular biochemical pathways, which ultimately turn genes on and off (Markert 1968; Trosko et al., 1993; Trosko and Ruch, 1998) . These intracellular pathways are all under the homeostatic control of neighboring cells, and involve intercellular communication through gap junctions Trosko et al., 1990a; Trosko et al., 1994; Trosko et al. 1990b,c; Trosko and Ruch, 1998) . Therefore, the control of epigenetic events depends on the intricate coordination of extra-, intra-, and inter-cellular network of pathways.
The cell proliferative stages of tumor promotion specifically involve the removal of a quiescent, initiated cell from growth suppression by neighboring cells, which would involve the reduction of gap junctional intercellular communication and the activation of mitogenic intracellular pathways (Trosko and Ruch, 1998) . Evidence suggesting that the reduction of GJIC is involved in carcinogenesis (Goldberg et al., 1994; Ruch et al., 1995; Temme et al., 1997; Trosko and Ruch, 1998; Yamasaki and Naus, 1996) includes the following: (a) most cancer cells have dysfunctional GJIC; (b) endogenous and exogenous tumor promoters reversibly inhibit GJIC; (c) oncogenes inhibit GJIC and antitumor promoters up-regulate GJIC; (d) transfection of gap junction genes into GJIC-deficient and tumorigenic cells restores GJIC and normal growth regulation; (e) antisense gap junction genes transfected into cancer cells augments foci formation; and (f) knock-out mice of connexin32, the major gap junction protein of the liver, had a 25-fold higher rate of spontaneous tumors. Intraperitoneal injection of the liver-tumor-initiating compound, DEN, led to large increases in liver weight due to massive tumor growth in Cx32 knockout mice, relative to the wild-type control.
As noted above, intercellular events modify the intracellular proliferative steps of tumor promotion. The intracellular pathways that are typically activated by a proliferative stimulus are the extracellular response kinases (ERK), one of the 3 known classes of MAPK (Denhardt, 1996) . This pathway is usually activated through a tyrosine kinase membrane receptor, which in turn activates a membrane-bound GTPase-Ras protein complex. Ras then initiates a cascade of kinases starting with the serine/threonine kinase MEK, which directly activates, by phosphorylation, ERK 1 and ERK 2 (Denhardt, 1996) . Once activated, the ERKs translocate to the nucleus and activate, via phosphorylation, various transcription factors such as the ternary complex factor ELK-1, which is involved in c-fos induction (Hill et al., 1993; Marais et al., 1993; Rao and Reddy, 1994; Zinck et al., 1993) . ERK also activates c-jun independent of the JNK/SAPK MAPK pathway (Kyriakis et al., 1994; Pulverer et al., 1991) .
Chemicals, such as PAHs, that contribute to the promoting stages of cancer could also alter these signalling pathways (Trosko and Ruch, 1998; Upham et al., 1998) . Recently, benzo(a)pyrene was shown to induce the MAPK, c-jun N-terminal kinase 1 (Lei et al., 1998) , but the effect of this and other PAHs on the ERK-class of MAPK is not known. However, PAHs are known to inhibit GJIC (Upham et al., 1994 (Upham et al., , 1995 (Upham et al., , 1996 Weis et al., 1998) . The inhibition of GJIC is dependent upon the structure of the PAHs . PAHs containing bay or bay-like regions ( Fig. 1) were more potent inhibitors of GJIC than their linear counterparts (Upham et al., 1996 Weis et al., 1998) . In particular, the linear PAHs anthracene and 2-methylanthracene had no effect on GJIC, whereas, 1-and 9-methylanthracene, which both contain a bay-like region, were very effective GJIC inhibitors Weis et al., 1998) .
In this study, we investigated the temporal relationship between alteration of GJIC and activation of ERK-type MAPK during exposure of cells to chlorinated and methylated anthracene isomers. Our results show that anthracene isomers containing bay-like regions were potent inducers of the ERK-type MAPK, in addition to being inhibitiors of GJIC. Inhibition of GJIC preceded the activation of MAPK. We also showed that the chlorinated isomers of anthracene, which are structurally similar but chemically different from the methyl isomers, had the same effect on GJIC as did the methylated isomers of anthracene. We conclude that the structure, and not the chem- ical reactivity of the PAHs, was the major determinant in the inhibition of GJIC and the activation of ERK-type MAPK.
MATERIALS AND METHODS
Chemicals. Anthracene, 1-, 2-, and 9-methylanthracenes, 1-, 2-and 9-chloroanthracenes, and formaldehyde (37%) were obtained from Aldrich Chemical Co., Inc. (Milwaukee, WI). Neutral red, and Lucifer yellow were obtained from Sigma Chemical Co. (St. Louis, MO). Acetonitrile was obtained from EM Science (Gibbstown, NJ).
Stock solutions. PAHs were dissolved in 100% acetonitrile. The concentrations of the stock solutions were 20 mM. The volumes of the stock solutions added directly to the culture medium in each plate ranged from 2 to 30 l. Vehicle controls were added to the cells at a volume of acetonitrile equivalent to the volume of PAH stock solution used. Acetonitrile is used because it is non-cytotoxic and non-inhibitory up to 2% (v/v) (Upham et al., 1995) . Cells were exposed to a maximum of 1.8% (v/v) acetonitrile in culture medium.
Cell cultures. WB-F344 rat liver epithelial cell lines were obtained from Drs. J. W. Grisham and M. S. Tsao of the University of North Carolina (Chapel Hill, NC) (Tsao et al., 1984) . This cell line was used because much of the in vivo tumor promotion assays were done in rat liver, specifically in the Fischer 344 rats. The WB-344 cell line was designed to match in vitro work in a liver cell line from the same strain of rat. Also, the WB-cells are from an immortalized, diploid cell line that is non-tumorigenic (Tsao et al., 1984) , and which has been well characterized in many laboratories for its expressed gap-junction genes and its ability to perform GJIC using all available techniques (Trosko et al., 1993) . This cell line has been tested with many types of tumor-promoting chemicals for their ability to block GJIC (Trosko et al., 1993) , and tested for the ability of growth factors and oncogenes to modulate GJIC (Trosko et al., 1993) .
Cells were cultured in 2 ml of D-medium (Formula No. 78 -5470EG, GIBCO Laboratories, Grand Island, NY) supplemented with 5% fetal bovine serum, unless otherwise indicated (GIBCO) and 50 g/ml gentamicin (GIBCO). The cells were grown in 35-mm diameter plastic petri dishes (Corning Glass Works, Corning, NY) and incubated at 37°C in a humidified atmosphere containing 5% CO 2 and 95% air. Bioassays were conducted on confluent cells that were obtained after 2 to 3 days of growth.
Chemical treatments. In the dose-response experiments, cells were exposed to different doses of the target compound for a set period. Threshold values for inhibitory doses were determined. In the time response experiments, cells were exposed for various lengths of time to the target compound at a dose that was known to cause inhibition of GJIC.
In the time recovery experiments, cells were exposed to the target compound at a dose and for a length of time that caused inhibition of GJIC. Following chemical exposure, the PAH-containing medium was discarded, cells were washed 3 times with PBS, and were re-cultured in fresh PAH-free medium for several incubation times. The above experiments were all done in serumsufficient medium except in Figure 6 , where the SL/DT assays were done on cells deprived of serum for 20 h.
GJIC. GJIC was determined by using the scrape loading/dye transfer (SL/DT) assay adapted from El-Fouly et al. (1987) and described in detail by Upham et al (1995) . Briefly, after treatment with the PAH, cells were rinsed 3 times with phosphate-buffered saline (PBS) and then 1 mg/ml was added of Lucifer Yellow, a fluorescent dye, dissolved in PBS. Three scrapes with a surgical steel scalpel were made through the cell monolayer to introduce this membrane-impermeable dye into the cells. After 3 min at room temperature, the dye solution was discarded, the cells rinsed 3 times with PBS, and then fixed with 4% formalin solution. The migration of the dye through gap junctions was photographed at 200ϫ using a Nikon epifluorescent microscope. The distance the dye traveled was measured perpendicular from the scrape and reported as a fraction of the control (FOC). An FOC value of approximately 1.0 indicates normal GJIC, and FOC values less than one indicate inhibition. The rate of dye migration in the control was measured by dividing the average distance the dye traveled in m by 3 min, which is the time allowed for dye migration through gap junctions. All experiments were done at least in triplicate and the results were reported as an average Ϯ the standard deviation at the 95% confidence interval. A Student's paired t-test was done to compare the threshold values of dose-and time-responses to GJIC vs. the vehicle controls. SigmaStat 2.0 (Jandel Corp, San Rafael, CA) was used for these statistical computations.
Cytotoxicity. Cytotoxicity was determined by the neutral-red dye uptake assay, developed by Borenfreund and Puerner (1985) and described in detail for our cell system by Weis et al (1998) . Cytotoxicity was reported as an FOC. The average rate of dye uptake by the control cells was 1.09 Ϯ 0.19 O.D 540nm /h. An FOC value of approximately 1.0 indicates that the neutral red uptake was equivalent to that of the vehicle control. An FOC value of less than one indicates that less neutral red was taken up by the system cells than by the cells of the controls. A Student's paired t-test was done to compare cytotoxicity at a dose that was close to the threshold dose determined in the dose response of GJIC vs. the vehicle controls. However, the normality test failed for 1-chloroanthracene and a Mann-Whitney Rank Sum Test was done instead of the t-test. SigmaStat 2.0 (Jandel Corp, San Rafael, CA) was used for these statistical computations.
Western blot analysis of ERK 1 and 2. Cells were grown in 35-mmdiameter tissue culture plates from Corning (Corning, NY) to the same confluency as the SL/DT assay. These cells were deprived of serum for 18 -24 h to synchronize them into G o arrest, and reduce the background levels of ERK activity. The positive control for MAPK activation was through cells treated with epidermal growth factor (EGF) at 10 ng/ml for 15 min. These were treated by PAHs under the same conditions as the SL/DT assay. The proteins were extracted with 20% SDS solution containing 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM leupeptin, 1 mM antipain, 0.1 mM aprotinin, 0.1 mM sodium orthovanadate, 5 mM sodium fluoride. The protein content was determined using the DC assay kit (Bio-Rad Corp., Richmond, CA). The proteins were separated on 12.5% SDS-PAGE according to the method of Laemmli (1970) . Fifteen g of protein was loaded onto the gels, which were run for approximately 1 h at 200 V. The proteins were electrophoretically transferred from the gel to PVDF membranes (Millipore Corp, Bedford, MA) for approximately 12-18 h at 20 V. Phosphorylated and unphosphorylated ERK 1 and ERK 2 was detected with a 1:2000 dilution of anti-phospho-ERK and anti-ERK polyclonal antibodies for 24 h, respectively (New England Biolabs, Beverly, MA). The protein-primary antibody complex was probed with a 1:1000 dilution of HRP-conjugated anti-rabbit antibodies (Amersham Life Science Products, Arlington Heights, IL) for 1 h. The ERK protein bands were detected using the Super Signal chemiluminesence detection kit (Pierce Corp., Arlington Heights, IL) and ECL Hyperfine X-ray film. The data were scanned on an Epson ES-1200c scanner (Sieko Epson Corp., Japan). Semi-quantitative information of bands was obtained using Sigma Gel ver. 1.0 (Jandel Scientific, San Rafael, CA).
RESULTS

Effect of PAHs on GJIC
Anthracene, 2-chloroanthracene, and 2-methylanthracene did not inhibit GJIC up to a dose of 350 M (Fig. 2) . Statistical analyses showed no significant differences between the vehicle controls and 300 M. 1-Methylanthracene, 9-methylanthracene, 1-chloroanthracene, and 9-chloroanthracene inhibited GJIC at 70 to 80 M (Fig. 2) . Statistical analyses showed significant differences between the vehicle controls and 70 M for the 1-, 9-monomethyl and dimethylanthracenes and 75 M for the 1-and 9-chloroanthracenes. Inhibition of GJIC by the 1-and 9-substituted isomers of anthracene occurred within 5 min (Fig. 3) . GJIC remained inhibited after 24 h of treatment with the isomers containing bay-like regions whereas there was no inhibition of GJIC by the linear isomers after 24 h (data not shown). Statistical analyses showed significant differences between the vehicle controls and the 5-min treatment with the inhibitory PAHs. When the cells were allowed to recover in fresh media, in the absence of the target compound, GJIC was significantly restored within the first h and was completely restored within 4 h (Fig. 4) . Dose response, time response and the rate of recovery were similar for all of the compounds tested (Figs. 2, 3, 4) . None of the PAHs were cytotoxic at the doses used in this study (Fig. 5) . Statistical analyses showed no significant differences between the vehicle controls and a dose of 60 M for the PAHs that inhibited GJIC.
Effect of PAHs on MAPK
Anthracene, 2-chloroanthracene, and 2-methylanthracene did not induce the phosphorylation of ERK 1 and ERK 2 (Fig.  6) . The levels of total MAPK for each compound at all time points were the same (data not shown). 1-Methylanthracene, 9-methylanthracene, 1-chloroanthracene, and 9-chloroanthracene, which inhibited GJIC at 70 M, transiently induced the phosphorylation of ERK 1 and ERK 2 at this same concentration (Fig. 6) . Activation of ERK 1 and ERK 2 by the 1-and 9-substituted isomers of anthracene occurred within 30 min, except for 9-chloroanthracene which transiently activated ERK phosphorylation within 15 min (Fig. 6) . The phosphorylation of ERK significantly decreased after 120 min for all but 9-chloroanthracene, which still had a high degree of phosphorylation (Fig. 6) . The GJIC activity that was measured at the time of protein extraction followed the same pattern of inhibition observed in Figure 2 , in which only the isomers containing a bay-like region inhibited GJIC, as indicated by the (-) symbols in Figure 6 . This indicates that the lack of serum did not alter the effects of these compounds on GJIC. In addition, we did the same experiments in serum containing medium and got the same results of MAPK-induction, except that there were notable levels of phosphorylated ERK1 and 2 in the controls (data not shown). The EGF-positive control completely inhibited GJIC within 15 min. A graphical representation of the densiometric measurements of the MAPK bands is shown in Figure 7 .
DISCUSSION
Carcinogenic studies on the structure-activity relationships of PAHs has focused on genotoxic properties (Hoffman et al., 1982; Jerina et al., 1978; Silverman and Low, 1982) . We recently have reported an epigenetic effect of PAHs on the alteration of GJIC (Upham et al., 1994 (Upham et al., , 1995 and further demonstrated that PAHs with bay or bay-like regions were more potent inhibitors of GJIC than their linear counterparts (Upham et al., 1996 Weis et al., 1998) . The term "bay-like region" (Upham et al., 1996) was used to describe the angular pocket formed at the top of the benzene ring by an alkyl group (Fig. 1) . This term "bay-like" does not refer to the bay regions formed by the well-known DNA reactive diolepoxides (Slaga et al., 1980) but rather to the unmetabolized parent structure. Our focus is on the epigenetic properties of the nonmetabolized PAH.
The biological effect of the chlorinated isomers on GJIC were the same as the methylated isomers (Figs. 2, 3, 4, 5) . The chlorinated isomers of anthracene that formed bay-like regions inhibited GJIC at the same doses (Fig. 2) and times (Fig. 3) and recovered from inhibition at similar rates (Fig. 4) to the methylated isomers of anthracene. In contrast, 2-chloroanthracene, 2-methylanthracene, and anthracene, which possess no baylike region, did not inhibit GJIC (Fig. 2) . Multiple bay-like regions, which exist on the dimethylanthracene (Fig. 1) , did not increase or decrease the activity relative to dose (Fig. 2) , time (Fig. 3) , or time of recovery (Fig. 4) . These results suggest that the effect of the various anthracenes on GJIC depend on their structural and not their chemical attributes. The chlorinated vs. methylated isomers are structurally very similar but differ in 
FIG. 6.
The stimulation of ERK, a MAPK, in response to the various anthracene isomers. Normal GJIC is indicated by ϩ; complete inhibition of GJIC (measured at the time the proteins were harvested for ERK determination in the serum-deprived cells) is indicated by -. The concentrations of the various anthracene isomers were 70 and 80 M for the methyl-and chloroisomers, respectively. The concentration of EGF was 10 ng/ml. These are representative data from 4 separate experiments.
FIG. 7.
Temporal relationship between MAPK activation and GJIC activity in response to anthracene isomers containing bay-like regions. The MAPK data are from densiometric scans of the bands shown in Figure 6 . GJIC data was normalized to 15 so that the scale for MAPK activation was equivalent to GJIC activity. their chemical reactivity. The highly electronegative chlorine withdraws electrons from the benzene ring, acting as a weak deactivator, but unlike most deactivating groups, which are meta directors, chlorine acts as an ortho/para directing nucleophile (Solomon, 1987) . In contrast, methyl groups tend to be electron donators rather than electron withdrawers (Solomon, 1987) .
These biological responses to PAHs containing bay-like regions are not limited to the regulation of GJIC but also activated the ERK-family of MAPK (Fig. 6) . The induction of ERK 1 and ERK 2 phosphorylation occurred in 30 min for the 1-chloroanthracene, 1-and 9-methylanthracene, and in 15 min for 9-chloroanthracene (Figs. 6 and 7) . These MAPK-activity induction times began after the inhibition of GJIC, which occurred in less than 5 min (Figs. 3 and 7) . These results indicate that the activation of ERK 1 and ERK 2 are not involved in the initial inhibition of GJIC by the anthracenes containing bay-like regions. Conversely, the inhibition of GJIC may be, in some way, a trigger in the activation of ERK 1 and 2. In addition, these kinetic data do not rule out the possibility that ERKs could maintain extended inhibition of GJIC. This is particularly so since the activation of ERK 1 and ERK 2 has been implicated in the direct regulation of gap junction function (Hossain et al., 1998; Kanemitsu and Lau, 1993; WarnCrammer et al., 1996 WarnCrammer et al., , 1998 , and the indirect regulation of gap junctions via the decrease in phosphatase activity due to MAPK activity (Wilson et al., 1998) .
The biological significance of our results illustrates how an epigenetic toxicant with a defined structural determinant can activate a pleiotropic set of interrelated cell-signalling events known to be involved in the cell-proliferative steps of growth and development of diseases such as cancer. Specifically, the decrease of GJIC is crucial in removing a cell from the homeostatic state of growth suppression (Trosko et al., 1983) . We explored this growth suppression phenomenon at a more mechanistic level by monitoring both the activity of GJIC and ERK, and we showed that the activity of GJIC declined prior to the activation of ERK (Figs. 3, 6, 7) . Hence, this inverse relationship we observed agrees with, although does not prove, the hypothesis that cells must first be removed from growth suppression via the inhibition of GJIC before the onset of mitogenic cell-signalling pathways.
Furthermore, these results also demonstrate that crucial molecular events of cell proliferation do not necessarily have to be linearly linked. Although our results do not prove that the molecular end points we measured were mediated via the same pathway, they did show that very specific structural determinants induce mutually important cell phenomena of cell proliferation. For example, the anthracenes containing bay-like regions formed by either a chlorine or a methyl group were all very similar in their inhibition of GJIC (Figs. 2-4 ), but differed slightly in the time of phosphorylation of ERK 1 and ERK 2 (Figs. 6, 7) .
Our in vitro results also agree with the observed phenomena that tumor promotion is reversible, in which the removal of the PAH from the culture medium resulted in the recovery of GJIC (Fig. 4) . The short incubation time required for the inhibitory PAHs to block GJIC (Fig. 3) suggests that the gap junction proteins are probably post-translationally modified. The transient time of MAPK activation by the GJIC-inhibitory PAHs also agrees with published results in which the ERKs are known to phosphorylate upstream-signalling elements and to activate various phosphatases, leading to a negative feedback system that deactivates ERK (Denhardt, 1996) . The PAHs we studied are environmentally significant. The methylated anthracenes are prevalent in the environment, although the chlorinated anthracenes are not (Neff, 1979) . The greatest human exposure to the methylated PAHs comes from cigarette smoke inhalation. Cigarette smoke has been shown to have tumor-promoting activity, which is a reversible epigenetic effect (Birrer et al., 1992; Nesnow et al., 1984; Weisburger and Wynder, 1984) . Furthermore, cigarette smoke is known to inhibit GJIC (Hartman and Rosen, 1983; Rutten et al., 1985; Vang et al., 1995) . Using mouse skin bioassays, the most tumorigenic portion of cigarette smoke condensates was shown to be the PAH-rich neutral fraction (Bock et al., 1969; Severson et al., 1976) . The most abundant PAHs in this neutral fraction are the methylated anthracenes and phenanthrenes (1494 ng/cigarette) (Severson et al., 1976) . Most of the remaining PAHs are phenanthrene, anthracene, methyl pyrene, pyrene, fluoranthene, chrysene, methyl chrysene, and benzo-(a)pyrene ranging in concentrations of 360 to 24 ng/cigarette in the order listed above (Severson et al., 1976) . Clearly, human exposure to the non-metabolized PAHs, with bay or bay-like regions, in cigarette smoke could play a significant role in the epigenetic-tumor-promoting properties of cigarette smoke. This is particularly significant, since the methylated forms of PAHs have been shown to be more carcinogenic than their parent counterparts (Flesher et al., 1990; Hecht et al., 1976; Hoffman et al., 1982; Kurihara et al., 1996; LaVoie et al., 1981 LaVoie et al., , 1985 Myers et al., 1988; Slaga et al., 1974) . Bioalkylation of non-methylated PAHs also occurs in vivo, often converting non-carcinogenic PAHs to carcinogenic PAHs (Flesher and Myers, 1991a,b; Flesher et al., 1990; Myers et al., 1991) .
In conclusion, the biological activity of an environmentally significant group of PAHs depends on a chemical structure that forms bay-like regions. These biologically active compounds first inhibited GJIC, followed by activation of the ERK-class of MAPK, which is an intracellular mitogenic pathway.
